Standard Operating Procedure for Handling and Use of Reference Standards in Analytical Method Development
| Department | Analytical Method Development |
|---|---|
| SOP No. | SOP/AMD/352/2025 |
| Supersedes | SOP/AMD/352/2022 |
| Page No. | Page 1 of 11 |
| Issue Date | 01/06/2025 |
| Effective Date | 03/06/2025 |
| Review Date | 01/06/2026 |
1. Purpose
The purpose of this SOP is to outline the procedures for the handling, qualification, storage, and use of primary and secondary reference standards in the Analytical Method Development (AMD) laboratory. Proper
2. Scope
This SOP is applicable to all reference standards used in the development and validation of analytical methods, including pharmacopeial, in-house, and working standards utilized within the AMD department.
3. Responsibilities
- Analyst: Requests reference standards and ensures appropriate handling during analytical use.
- AMD Documentation Officer: Maintains inventory records, logbooks, and qualification documents.
- Section Head: Verifies suitability, approves use, and ensures standards are within validity period.
- QA: Audits compliance with procedures and ensures traceability of all reference standards.
4. Accountability
The Head of Analytical Method Development is accountable for ensuring that reference standards are appropriately procured, qualified, stored, and used in accordance with applicable regulatory and internal requirements.
5. Procedure
5.1 Procurement of Reference Standards
- Obtain pharmacopeial standards (e.g., USP, EP, IP) from official agencies only.
- In-house standards must be synthesized or isolated under GMP conditions with full characterization data.
- Secondary working standards should be qualified against primary reference standards.
- All reference standards must be accompanied by a Certificate of Analysis (CoA), characterization report, and MSDS.
5.2 Receipt and Logging
- Upon receipt, inspect the reference standard for labeling, damage, and physical appearance.
- Enter the details in the Reference Standard Receipt Log (Annexure-1) including source, batch number, potency, and expiry date.
- Assign a unique identification number (e.g., RS/AMD/001/2025) for traceability.
5.3 Qualification of Working Standards
- Compare working standard purity and response factor with a qualified primary standard.
- Perform at least three replicate analyses to confirm assay reproducibility.
- Document qualification results using the format provided in Annexure-2.
- Only qualified and approved working standards should be used for routine AMD activities.
5.4 Labeling Requirements
Each vial or container must be labeled with the following:
- Reference ID
- Name of compound
- Purity or potency (%)
- Storage condition
- Date of receipt
- Expiry or requalification date
5.5 Storage Conditions
- Store standards in a designated refrigerator or controlled room with 2–8°C or ambient temperature as specified.
- Use desiccators or sealed containers to protect from moisture, light, or air exposure where applicable.
- Temperature monitoring and access control should be implemented as per Annexure-3.
5.6 Usage Guidelines
- Use reference standards only within their validity period.
- Record each usage in the Reference Standard Usage Log (Annexure-4) including analyst name, date, quantity used, and purpose.
- Avoid multiple freeze-thaw cycles and always use calibrated weighing balances.
5.7 Requalification and Disposal
- Requalify standards nearing expiry based on stability data or analytical comparison.
- If found unsuitable or expired, document and dispose as per SOP for hazardous waste disposal.
- Archive all records and CoAs for minimum 5 years.
6. Abbreviations
- RS: Reference Standard
- WS: Working Standard
- CoA: Certificate of Analysis
- MSDS: Material Safety Data Sheet
- GMP: Good Manufacturing Practice
7. Documents
- Annexure-1: Reference Standard Receipt Log
- Annexure-2: Working Standard Qualification Report
- Annexure-3: Storage Temperature Monitoring Log
- Annexure-4: Reference Standard Usage Log
8. References
- ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
- USP General Chapter <1225> – Validation of Compendial Methods
- WHO Technical Report Series No. 943
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | Akshay Mehra | Anita Joshi | Dr. Rakesh Rawat |
| Designation | Analyst – AMD | QA Reviewer | Head – Analytical Method Development |
| Department | Analytical Method Development | Quality Assurance | Analytical Method Development |
11. Annexures
Annexure-1: Reference Standard Receipt Log
| Date | Reference ID | Name | Purity | Source | Expiry | Status |
|---|---|---|---|---|---|---|
| 29/05/2025 | RS/AMD/003/2025 | Paracetamol | 99.5% | USP | 29/05/2026 | Active |
Annexure-2: Working Standard Qualification Report
Include results of assay, chromatographic purity, response factor comparison, and analyst’s summary.
Annexure-3: Storage Temperature Monitoring Log
| Date | Time | Location | Temperature (°C) | Recorded By |
|---|---|---|---|---|
| 01/06/2025 | 09:00 | Reference Standard Cabinet | 5.2 | A. Mehra |
Annexure-4: Reference Standard Usage Log
| Date | Reference ID | Quantity Used (mg) | Analyst | Purpose |
|---|---|---|---|---|
| 01/06/2025 | RS/AMD/003/2025 | 25.0 | A. Mehra | Assay Method Validation |
Revision History:
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 01/06/2025 | 2.0 | Added section on qualification and storage documentation | Annual SOP review | Dr. Rakesh Rawat |
| 01/06/2022 | 1.0 | Initial SOP release | New SOP | QA Head |